Aman U Buzdar

Aman U Buzdar

UNVERIFIED PROFILE

Are you Aman U Buzdar?   Register this Author

Register author
Aman U Buzdar

Aman U Buzdar

Publications by authors named "Aman U Buzdar"

Are you Aman U Buzdar?   Register this Author

100Publications

2835Reads

26Profile Views

A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.

Invest New Drugs 2018 04 27;36(2):299-306. Epub 2018 Jan 27.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Dan L. Duncan Building, CPB5.3542, 1515 Holcombe Blvd., Unit 1354, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-018-0564-2
Publisher Site
http://dx.doi.org/10.1007/s10637-018-0564-2DOI Listing
April 2018

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

J Clin Oncol 2017 Apr 30;35(10):1049-1060. Epub 2017 Jan 30.

W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455352PMC
April 2017

Combination endocrine treatments unproven in breast cancer.

Authors:
Aman U Buzdar

Lancet Oncol 2013 Sep 29;14(10):917-8. Epub 2013 Jul 29.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(13)70364-4DOI Listing
September 2013

Using multiple targeted therapies in oncology: considerations for use, and progress to date in breast cancer.

Drugs 2013 May;73(6):505-15

Department of Medical Oncology, Mater Misericordiae University Hospital and University College Dublin, Eccles St, Dublin 7, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-013-0044-0DOI Listing
May 2013

Making genuine progress against metastatic breast cancer.

J Clin Oncol 2012 Oct 27;30(28):3448-51. Epub 2012 Aug 27.

Duke University and the Duke Cancer Institute, 2424 Erwin Rd, Suite 205, Durham, NC 27705, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.6931DOI Listing
October 2012

Aromatase inhibitors in premenopausal breast cancer.

Lancet Oncol 2012 Apr 20;13(4):320-1. Epub 2012 Jan 20.

Department of Medical Oncology, Mater Misericordiae University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(11)70399-0DOI Listing
April 2012

Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.

Cancer Prev Res (Phila) 2012 Feb 18;5(2):276-82. Epub 2011 Nov 18.

Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0346DOI Listing
February 2012

Screening for cardiac risk before anthracycline administration: what are the real benefits?

Clin Breast Cancer 2012 Feb 29;12(1):1-3. Epub 2011 Nov 29.

Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2011.10.001DOI Listing
February 2012

Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia.

Cancer 2011 Jul 24;117(14):3268-75. Epub 2011 Jan 24.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25865DOI Listing
July 2011

Predictive algorithms for adjuvant therapy: TransATAC.

Steroids 2011 Jul 4;76(8):777-80. Epub 2011 Apr 4.

Academic Department of Biochemistry, Royal Marsden Hospital, Fulham Road, London SW36JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.steroids.2011.02.032DOI Listing
July 2011

Anti-angiogenic therapies in metastatic breast cancer-an unfulfilled dream.

Authors:
Aman U Buzdar

Lancet Oncol 2011 Apr 21;12(4):316-8. Epub 2011 Mar 21.

Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(11)70060-2DOI Listing
April 2011

Anastrozole.

Expert Opin Drug Saf 2010 Nov;9(6):995-1003

Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2010.515977DOI Listing
November 2010

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.

Cancer 2010 Jul;116(14):3348-56

The University of Texas M. D. Anderson Cancer Center, Section of Neuropsychology, Department of Neuro-Oncology, Houston, Texas 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25098DOI Listing
July 2010

Aromatase inhibitors alone or in sequence with tamoxifen - clinical evaluation of the BIG 1-98 trial.

Expert Opin Pharmacother 2010 Feb;11(3):489-92

The University of Texas M. D. Anderson Cancer Center, Department of Breast Medical Oncology, Unit 1354, PO Box 301439, Houston, TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656560903501551DOI Listing
February 2010

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review.

J Clin Oncol 2010 Jan 23;28(1):92-8. Epub 2009 Nov 23.

The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.9844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2799236PMC
January 2010

Evolving novel anti-HER2 strategies.

Lancet Oncol 2009 Dec;10(12):1179-87

Purdue University School of Pharmacy and Pharmaceutical Sciences, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(09)70315-8DOI Listing
December 2009

Medical oncology: Endocrine-therapy-related symptoms and breast cancer.

Authors:
Aman U Buzdar

Nat Rev Clin Oncol 2009 Jun;6(6):309-10

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2009.67DOI Listing
June 2009

Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer.

J Clin Oncol 2008 Oct 25;26(30):4891-8. Epub 2008 Aug 25.

Department of Breast Medical Oncology and Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.1168DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736998PMC
October 2008

Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.

Lancet Oncol 2008 Sep 12;9(9):866-72. Epub 2008 Aug 12.

Cancer Research UK, Centre for Epidemiology, Mathematics, and Statistics, Wolfson Institute of Preventive Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(08)70182-7DOI Listing
September 2008

Fulvestrant--a novel estrogen receptor antagonist for the treatment of advanced breast cancer.

Authors:
Aman U Buzdar

Drugs Today (Barc) 2008 Sep;44(9):679-92

The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1358/dot.2008.44.9.1256862DOI Listing
September 2008

Staging of breast cancer in the neoadjuvant setting.

Cancer Res 2008 Aug;68(16):6477-81

Department of Surgery, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4441792PMC
August 2008

Arzoxifene: the evidence for its development in the management of breast cancer.

Core Evid 2008 Jul 31;2(4):251-8. Epub 2008 Jul 31.

Professorial Unit of Surgery, Nottingham City Hospital, Nottingham, UK;

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012444PMC
July 2008

Clinical experience with epothilones in patients with breast cancer.

Authors:
Aman U Buzdar

Clin Breast Cancer 2008 Mar;8 Suppl 2:S71-8

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S1526820911709284/1-s2.0-S152682091170
Web Search
http://dx.doi.org/10.3816/cbc.2008.s.003DOI Listing
March 2008

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.

Cancer 2008 Feb;112(3 Suppl):700-709

Breast Oncology Center, Dana Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23193DOI Listing
February 2008

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

J Clin Oncol 2008 Feb;26(5):814-9

Seattle Cancer Care Alliance, Department of Medicine, 825 Eastlake Ave, EMS G3-200, Seattle, WA 98109-1023, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.3510DOI Listing
February 2008

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.

J Clin Oncol 2008 Jan 3;26(2):246-52. Epub 2007 Dec 3.

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.5352DOI Listing
January 2008

Recent advances in the hormonal treatment of breast cancer.

Curr Probl Surg 2008 Jan;45(1):13-55

Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1067/j.cpsurg.2007.10.004DOI Listing
January 2008

Preoperative chemotherapy treatment of breast cancer--a review.

Authors:
Aman U Buzdar

Cancer 2007 Dec;110(11):2394-407

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23083DOI Listing
December 2007

Phase III double-blind trial of arzoxifene compared with tamoxifen for locally advanced or metastatic breast cancer.

J Clin Oncol 2007 Nov;25(31):4967-73

Department of Surgical Oncology, Kidwai Memorial Institute of Oncology, Karnataka, Bangalore, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.09.5992DOI Listing
November 2007

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

J Clin Oncol 2007 Oct 4;25(28):4414-22. Epub 2007 Sep 4.

Department of Pathology, Unit 85, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.10.6823DOI Listing
October 2007

Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.

Cancer 2007 Sep;110(6):1195-200

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22895DOI Listing
September 2007

Trends for inflammatory breast cancer: is survival improving?

Oncologist 2007 Aug;12(8):904-12

Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.12-8-904DOI Listing
August 2007

Adjuvant chemotherapy for high-risk operable breast cancer.

Authors:
Aman U Buzdar

J Clin Oncol 2007 May 2;25(13):1642-4. Epub 2007 Apr 2.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.09.9796DOI Listing
May 2007

Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer.

Authors:
Aman U Buzdar

J Clin Oncol 2007 May;25(15):2147-8; author reply 2148

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.2755DOI Listing
May 2007

Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin).

Breast J 2007 Jan-Feb;13(1):72-5

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2006.00366.xDOI Listing
March 2007

Aromatase inhibitors: changing the face of endocrine therapy for breast cancer.

Authors:
Aman U Buzdar

Breast Dis 2005-2006;24:107-17

Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/bd-2006-24109DOI Listing
October 2006

Fulvestrant: pharmacologic profile versus existing endocrine agents for the treatment of breast cancer.

Ann Pharmacother 2006 Sep 15;40(9):1572-83. Epub 2006 Aug 15.

Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1345/aph.1G401DOI Listing
September 2006

Impact of chemotherapy regimens prior to endocrine therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial.

Cancer 2006 Aug;107(3):472-80

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22042DOI Listing
August 2006

Anastrozole for breast cancer: recent advances and ongoing challenges.

Authors:
Aman U Buzdar

Expert Rev Anticancer Ther 2006 Jun;6(6):839-48

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.6.839DOI Listing
June 2006

Update on the management of inflammatory breast cancer.

Authors:
Aman U Buzdar

Clin Adv Hematol Oncol 2006 May;4(5):344-5

Department of Breast Medical Oncology, The University of Texas, M. D. Anderson Cancer Center, TX, USA.

View Article

Download full-text PDF

Source
May 2006

Letrozole or tamoxifen in early breast cancer.

N Engl J Med 2006 Apr;354(14):1528-30; author reply 1528-30

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/abs/10.1056/NEJMc060194
Publisher Site
http://dx.doi.org/10.1056/NEJMc060194DOI Listing
April 2006

Anastrozole as an adjuvant endocrine treatment for postmenopausal patients with breast cancer: emerging data.

Clin Cancer Res 2006 Feb;12(3 Pt 2):1037s-1048s

The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2458DOI Listing
February 2006

Dietary modification and risk of breast cancer.

Authors:
Aman U Buzdar

JAMA 2006 Feb;295(6):691-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.295.6.691DOI Listing
February 2006

Adjuvant systemic therapy for male breast carcinoma.

Cancer 2005 Dec;104(11):2359-64

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21526DOI Listing
December 2005

Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer.

J Clin Oncol 2005 Nov;23(33):8544-6; author reply 8546-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.7416DOI Listing
November 2005

Preoperative chemotherapy for breast cancer.

Authors:
Aman U Buzdar

Clin Adv Hematol Oncol 2004 Apr;2(4):212, 215

Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, TX, USA.

View Article

Download full-text PDF

Source
April 2004